000
| 01856nam 2200397zi 4500 |
---|
001 | 9.871533 |
---|
003 | CaOODSP |
---|
005 | 20221107163420 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 190412t20192019onc o f000 0 eng d |
---|
020 | |a9780660304977 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH14-318/2019E-PDF |
---|
245 | 00|aGuidance document : |breconsideration of decisions issued for human drug and natural health product submissions / |cpublished by authority of the Minister of Health ; Health Products and Food Branch. |
---|
246 | 30|aReconsideration of decisions issued for human drug and natural health product submissions |
---|
246 | 17|aHealth Canada guidance document : |breconsideration of decisions issued for human drug and natural health product submissions |
---|
264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2019. |
---|
264 | 4|c©2019 |
---|
300 | |a1 online resource (32 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Ligne directrice : révision des décisions sur les présentations de drogue pour usage humain et les produits de santé naturels. |
---|
500 | |aCover title. |
---|
500 | |a"Effective Date: 2019/04/01." |
---|
500 | |a"Pub.: 190002." |
---|
530 | |aIssued also in print format. |
---|
692 | 07|2gccst|aDrugs |
---|
692 | 07|2gccst|aGovernment policy |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
710 | 1 |aCanada. |bHealth Products and Food Branch. |
---|
775 | 08|tLigne directrice : |w(CaOODSP)9.871540 |
---|
776 | 0#|tReconsideration of decisions issued for human drug and natural health product submissions.|w(CaOODSP)9.871537 |
---|
856 | 40|qPDF|s429 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H14-318-2019-eng.pdf |
---|